Clinical Trials in Seattle

Showing 4861-4880 of 7,135 trials

Sequence of Symptom Change During AUD or PTSD Treatment for Comorbid PTSD/AUD

NCT01663337

The broad, long-term objective of the current research is to improve treatment outcomes for individuals with comorbid posttraumatic stress disorder (PTSD) and alcohol abuse and dependence (AUD). The purpose of which is to evaluate changes in both PTSD symptoms and alcohol use and cravings associated with Cognitive Processing Therapy (CPT) or Relapse Prevention (RP) treatment in individuals with PTSD/AUD, along with mediators and moderators of outcomes. The study will randomize 235 PTSD/AUD participants recruited from the VA and from the community to CPT, RP, or Interactive Voice Response (IVR) assessment only (AO). Those in the AO condition will be re-randomized after the treatment phase to either RP or CPT. Individuals will be assessed pretreatment, immediately post-treatment, 3-, 6-, 9-, and 12-months post-treatment and will monitor symptoms daily throughout treatment.

PTSDAlcohol AbuseAlcohol Dependence

University of Washington235 participantsStarted Mar 2013

Seattle, Washington, United States • Seattle, Washington, United States

COMPLETEDPhase 3< 1 mile

Eslicarbazepine Acetate Monotherapy Long Term Study

NCT00910247

This is a long term, open-label, safety extension study in subjects with partial onset seizures.

Epilepsy

Sumitomo Pharma America, Inc.274 participantsStarted Aug 2009

Northport, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +119 more locations

Sequence of Symptom Change During AUD or PTSD Treatment for Comorbid PTSD/AUD

Eslicarbazepine Acetate Monotherapy Long Term Study

Find Trials by Condition in Seattle

Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay

Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor

Study of the Safety and Immune Response of a Meningococcal Conjugate Vaccine Administered to Healthy Adolescents

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

Safety & Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

The Advocate Study

Clazosentan in Aneurysmal Subarachnoid Hemorrhage

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)